Home > Analytics > MEDPLUS HEALTH SERVICES

MEDPLUS HEALTH SERVICES
Intrinsic Value | Fundamental Analysis

BOM : 543427     NSE : MEDPLUS    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : NA
Feb 06,2023
Price(EOD): ₹ 655.45
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 7,819.52 Cr
Value of ₹ 1 Lac invested in MEDPLUS HEALTH SERVICES
on Dec 23,2021 (price: ₹ 1,120.85)

₹ 1 L

₹ 0.58 L

1W : 3.1% 1M : 7.5% 1Y : -42.4%
COMMUNITY POLL
for MEDPLUS HEALTH SERVICES
Please provide your vote to see the results
MEDPLUS HEALTH SERVICES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Industry Peers & Returns1W1M1Y
MEDPLUS HEALTH SERVICES 3.1% 7.5% -42.4%
SUN PHARMACEUTICAL INDUSTRIES -1.1% 0.8% 15.6%
DIVIS LABORATORIES -16.3% -19.7% -31.6%
CIPLA 1.3% -5.4% 7.5%
DR REDDYS LABORATORIES 0.6% 1.3% -1.3%
TORRENT PHARMACEUTICALS 1.2% -1.3% 12%
ABBOTT INDIA 0.2% -5.5% 28.7%
ZYDUS LIFESCIENCES 9.2% 8.7% 4.7%
ALKEM LABORATORIES 2% 0.9% -14%

FUNDAMENTAL ANALYSIS OF MEDPLUS HEALTH SERVICES

 
Fundamentals Score
[ Q(TTM): Dec2022, Y: Mar2022
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]

Insights 💡 MEDPLUS is one of the top 35% companies with good fundamentals ! Discover More →

VALUATION OF MEDPLUS HEALTH SERVICES

 
Valuation Score
[As on : Feb 06,2023 ]

Ratio Consolidated
P/E
P/B
P/S
223.63
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 34.97 Cr
[Latest Qtr - Dec2022 - Consolidated Results ]

5.56
P/B Calculated based on Book Value of Rs 1,406.38 Cr
[Latest Year - Mar2022 - Consolidated Results ]

1.83
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 4,270.50 Cr
[Latest Qtr - Dec2022 - Consolidated Results ]

Financial Ratios →

Insights 💡 There are potential 29% undervalued companies ! Discover More →

FAIR VALUE OF MEDPLUS HEALTH SERVICES

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
2662%
20512%
-48%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF MEDPLUS HEALTH SERVICES



MEDPLUS HEALTH SERVICES vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF MEDPLUS HEALTH SERVICES

Year Debt/Equity ratio
Standalone Consolidated
2022
2021
2020
Avg_3yrs
0
0
0
-
0.1
0.2
0.36
0.22
[Last Annual Data : Mar2022]
Financial Ratios →

PLEDGED PROMOTER SHARES OF MEDPLUS HEALTH SERVICES

Pledged Promoter Shares
NA

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF MEDPLUS HEALTH SERVICES

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
6.22%
20.21%
83.76%
106.56%
27.52%
16.75%
-25.46%
-20.9%
QtrlyTrend
4
Latest Qtr: Dec2022
Quarterly Result Analysis →


MEDPLUS HEALTH SERVICES related INDICES

BSE Indices1W1M1Y
S&P BSE 250 SMALLCAP 2% -2.7% -5.1%
S&P BSE 400 MIDSMALLCAP 1.8% -2.2% -1.7%
S&P BSE CONSUMER DISC. 1.5% -1.2% -2.7%
S&P BSE SMALL CAP 1.5% -3.4% -5.1%
S&P BSE MIDSMALLCAP 1.5% -3% -3.2%
NSE Indices1W1M1Y
NIFTY FREE SMALL 100 2.5% -2.7% -15.3%
NIFTY SMALLCAP 50 2.3% -1.8% -17.6%
NIFTY SMALLCAP250 1.8% -3.1% -7.1%
NIFTY MID SMALL400 1.7% -2.6% -1.8%
NIFTY500 MULTICAP 50:25:25 1% -2.9% -2.1%

You may also like the below Video Courses


FAQ about MEDPLUS HEALTH SERVICES


Is MEDPLUS HEALTH SERVICES good for long term investment?

As on Feb 06,2023, the Fundamentals of MEDPLUS HEALTH SERVICES look Strong and hence it may be good for long term investment! See Financial Performance of MEDPLUS HEALTH SERVICES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is MEDPLUS HEALTH SERVICES UnderValued or OverValued?

As on Feb 06,2023, MEDPLUS HEALTH SERVICES is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of MEDPLUS HEALTH SERVICES ?

As on Feb 06,2023, the Intrinsic Value of MEDPLUS HEALTH SERVICES is Rs. 23.73 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 23.73
Fair Value [Median EV / Sales Model] : Rs. 3.18
Fair Value [Median Price / Sales Model] : Rs. 1,266.39
Estimated Median Fair Value of MEDPLUS HEALTH SERVICES : Rs. 23.73

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is MEDPLUS HEALTH SERVICES trading at a Premium or Discount?

As on Feb 06,2023, MEDPLUS HEALTH SERVICES is trading at a Premium of 2662% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].